Skip to main content
Log in

Acute kidney injury is linked to higher mortality in elderly hospitalized patients with non-valvular atrial fibrillation

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Aim

Renal insufficiency is associated with medical complications in patients with non-valvular atrial fibrillation (NVAF). However, data for elderly patients are scarce. Thus, the main objectives of the present study were to analyze the characteristics of elderly patients with NVAF and acute or chronic renal disease, describe their management in real-life conditions, and detect factors associated with complications.

Methods

The NONAVASC registry includes patients > 75 years with NVAF, hospitalized by any cause in 64 Spanish Internal Medicine departments. Patients were categorized into acute kidney injury (AKI), chronic kidney disease (CKD) or preserved renal function (PRF). All variables associated with in-hospital mortality with P < 0.10 in univariate analysis were included to develop a multivariate logistic-regression model.

Results

The study included 804 patients (53.9% women), 352 (43.8%) of whom met diagnostic criteria for CKD. AKI was detected in 119 (14.8%) patients. AKI was associated with greater length of stay, higher mortality and an increased rate of patient transfer to nursing homes. After logistic-regression analysis, we found an association between mortality and AKI (OR 2.4, 95% CI 1.03–5.53; P = 0.045). The increase in creatinine values (OR 1.8, 95% CI 1.19–2.73; P = 0.005) and the decrease in albumin values (OR 2.0, 95% CI 1.05–3.73; P = 0.033) were also linked to mortality.

Conclusions

Our study shows the relationship between AKI and creatinine value increase and a higher mortality in elderly patients with NVAF. In light of our findings, the detection of renal function impairment in these patients should alert physicians and consider them as high-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chugh SS, Havmoeller R, Narayanan K et al (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129:837–847. https://doi.org/10.1161/CIRCULATIONAHA.113.005119

    Article  PubMed  Google Scholar 

  2. Heeringa J, van der Kuip DAM, Hofman A et al (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27:949–953. https://doi.org/10.1093/eurheartj/ehi825

    Article  PubMed  Google Scholar 

  3. Gómez-Doblas JJ, Muñiz J, Martin JJA et al (2014) Prevalence of atrial fibrillation in Spain. OFRECE study results. Rev Espanola Cardiol Engl Ed 67:259–269. https://doi.org/10.1016/j.rec.2013.07.014

    Article  Google Scholar 

  4. Suárez-Dono J, Cervantes-Pérez E, Pena-Seijo M et al (2016) CRONIGAL: prognostic index for chronic patients after hospital admission. Eur J Intern Med 36:25–31. https://doi.org/10.1016/j.ejim.2016.08.002

    Article  PubMed  Google Scholar 

  5. Wolf PA, Mitchell JB, Baker CS et al (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234

    Article  CAS  PubMed  Google Scholar 

  6. Lakshminarayan K, Solid CA, Collins AJ et al (2006) Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke 37:1969–1974. https://doi.org/10.1161/01.STR.0000230607.07928.17

    Article  PubMed  Google Scholar 

  7. Mant J, Hobbs FDR, Fletcher K et al (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham atrial fibrillation treatment of the aged study, BAFTA): a randomised controlled trial. Lancet Lond Engl 370:493–503. https://doi.org/10.1016/S0140-6736(07)61233-1

    Article  CAS  Google Scholar 

  8. Formiga F, Ferrer A, Henríquez E, Pujol R (2006) [Low percentage of oral anticoagulation in nonagenarians with atrial fibrillation]. Rev Clin Esp 206:410–411

    Article  CAS  PubMed  Google Scholar 

  9. Suárez Fernández C, Camafort M, Cepeda Rodrigo JM et al (2015) Antithrombotic treatment in elderly patients with atrial fibrillation. Rev Clin Esp 215:171–181. https://doi.org/10.1016/j.rce.2014.11.024

    Article  PubMed  Google Scholar 

  10. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893–2962. https://doi.org/10.1093/eurheartj/ehw210

    Article  PubMed  Google Scholar 

  11. Sardar MR, Badri M, Prince CT et al (2014) Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Intern Med 174:1868–1870. https://doi.org/10.1001/jamainternmed.2014.4758

    Article  PubMed  Google Scholar 

  12. Sardar P, Chatterjee S, Chaudhari S, Lip GYH (2014) New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. J Am Geriatr Soc 62:857–864. https://doi.org/10.1111/jgs.12799

    Article  PubMed  Google Scholar 

  13. Expósito V, Seras M, Fernández-Fresnedo G (2015) [Oral anticoagulation in chronic kidney disease with atrial fibrillation]. Med Clin (Barc) 144:452–456. https://doi.org/10.1016/j.medcli.2014.03.029

    Article  Google Scholar 

  14. Cho SW, Hwang JK, Chun KJ et al (2017) Impact of moderate to severe renal impairment on long-term clinical outcomes in patients with atrial fibrillation. J Cardiol 69:577–583. https://doi.org/10.1016/j.jjcc.2016.04.006

    Article  PubMed  Google Scholar 

  15. Gullón A, Suárez C, Díez-Manglano J et al (2017) Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry. Med Clin (Barc) 148:204–210. https://doi.org/10.1016/j.medcli.2016.10.042

    Article  Google Scholar 

  16. Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33:2719–2747. https://doi.org/10.1093/eurheartj/ehs253

    Article  PubMed  Google Scholar 

  17. Stevens PE, Levin A, Kidney Disease Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830. https://doi.org/10.7326/0003-4819-158-11-201306040-00007

    Article  PubMed  Google Scholar 

  18. Khwaja A (2012) KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 120:c179–184. https://doi.org/10.1159/000339789

    Article  PubMed  Google Scholar 

  19. Perneger TV (1998) What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiol Camb Mass 1:43–46

    Article  CAS  Google Scholar 

  21. Baber U, Howard VJ, Halperin JL et al (2011) Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol 4:26–32. https://doi.org/10.1161/CIRCEP.110.957100

    Article  PubMed  Google Scholar 

  22. Alonso A, Lopez FL, Matsushita K et al (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123:2946–2953. https://doi.org/10.1161/CIRCULATIONAHA.111.020982

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vázquez E, Sánchez-Perales C, Lozano C et al (2003) Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 92:868–871

    Article  PubMed  Google Scholar 

  24. Fraser SDS, Roderick PJ, May CR et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193. https://doi.org/10.1186/s12882-015-0189-z

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lim CC, Teo BW, Ong PG et al (2015) Chronic kidney disease, cardiovascular disease and mortality: a prospective cohort study in a multi-ethnic Asian population. Eur J Prev Cardiol 22:1018–1026. https://doi.org/10.1177/2047487314536873

    Article  PubMed  Google Scholar 

  26. Sarnak MJ (2003) Cardiovascular complications in chronic kidney disease. Am J Kidney Dis Off J Natl Kidney Found 41:11–17

    Article  Google Scholar 

  27. Hu W, He W, Liu W et al (2016) Risk factors and prognosis of cardiorenal syndrome type 1 in elderly chinese patients: a retrospective observational cohort study. Kidney Blood Press Res 41:672–679. https://doi.org/10.1159/000447936

    Article  CAS  PubMed  Google Scholar 

  28. Funk I, Seibert E, Markau S, et al. (2016) Clinical course of acute kidney injury in elderly individuals above 80 years. Kidney Blood Press Res 41:947–955. https://doi.org/10.1159/000452599

    Article  CAS  PubMed  Google Scholar 

  29. Santoro A (2012) Heart failure and cardiorenal syndrome in the elderly. J Nephrol 25 Suppl 19:S67–S72. https://doi.org/10.5301/jn.5000232

    Article  Google Scholar 

  30. Del Giudice A, Aucella F (2012) Acute renal failure in the elderly: epidemiology and clinical features. J Nephrol 25 Suppl 19:S48–S57. https://doi.org/10.5301/jn.5000141

    Article  Google Scholar 

  31. Berra G, Garin N, Stirnemann J et al (2015) Outcome in acute heart failure: prognostic value of acute kidney injury and worsening renal function. J Card Fail 21:382–390. https://doi.org/10.1016/j.cardfail.2014.12.015

    Article  PubMed  Google Scholar 

  32. Sanmartín-Fernández M, Marzal-Martín D (2016) Safety of non-vitamin K antagonist oral anticoagulants in clinical practice. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. https://doi.org/10.1177/1076029616668404

    Article  Google Scholar 

  33. Chertow GM, Burdick E, Honour M et al (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol JASN 16:3365–3370. https://doi.org/10.1681/ASN.2004090740

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to acknowledge all the investigators of the NONAVASC registry for collecting data for the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ignacio Novo-Veleiro.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Statement of human and animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novo-Veleiro, I., Pose-Reino, A., Gullón, A. et al. Acute kidney injury is linked to higher mortality in elderly hospitalized patients with non-valvular atrial fibrillation. Aging Clin Exp Res 31, 455–461 (2019). https://doi.org/10.1007/s40520-018-1001-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-018-1001-2

Keywords

Navigation